Psychedelic Stocks,Shroom News Optimi Health Enters Into a Psilocybin Supply Agreement With Halucenex By Dennis Mutua June 17, 2022 Pharmaceutical company offering formulation capsules, mushroom extracts and recreational psilocybin Optimi Health Corp. (CSE: OPTI) (OTCMKTS: OPTHF) announced having entered into a psilocybin supply agreement with Halucenex Life S...
Psychedelic Stocks,Shroom News Silo Wellness Requests Oregon Property Owners Interested in Participating in in the regulatory regime under Oregon Ballot Measure 109 to Come Forward By Dennis Mutua June 16, 2022 Psychedelic therapy company operating psychedelic clinics and developing legal functional mushroom consumer products Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) is requesting Oregon property owners who are interested in taking p...
Psychedelic Stocks,Shroom News Psychedelic Access and Research European Alliance (PAREA) Officially Launched By Dennis Mutua June 15, 2022 Psychedelic Access and Research European Alliance (PAREA) which is a non-profit making, multi-stakeholder and multi-disciplinary partnership bringing together medical associations, psychedelic foundations, patient organizations an...
Featured,Shroom News HAVN Life Sciences Inks a Mushroom Supply Agreement With Jamaican Cannabis Producer By Dennis Mutua June 10, 2022 Biotechnology company focusing on research, extraction, formulation and delivery of psychedelics HAVN Life Sciences Inc. (CSE: HAVN) (OTCMKTS: HAVLF) announced having entered into a mushroom supply agreement with Jamaica based Gre...
Psychedelic Stocks,Shroom News Lennham Pharmaceuticals Granted Patent Covering Methods of Administering Psilocybin and Psilocin By Dennis Mutua June 01, 2022 Healthcare company focusing on improving the metabolic and pharmacological profile of drugs through deuterium chemistry Lennham Pharmaceuticals announced having received a patent from United States Patent & Trademark Office (U...
Psychedelic Stocks,Shroom News Tryp Therapeutics Appoints Chris Ntoumenopoulos as an Independent Director By Dennis Mutua May 26, 2022 Pharmaceutical company focused on developing psilocybin based drugs for treatment of diseases with unmet medical needs Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) has appointed Chris Ntoumenopoulosto its board of directors a...
Psychedelic Stocks,Shroom News Canadian Senator Reveals He Takes Psilocybin to Battle Depression By Dennis Mutua May 24, 2022 Several days ago, Senator Larry Campbell from Canada disclosed that he has been microdosing with psilocybin to help battle depression. The Senator made the revelation during the Catalyst Psychedelics Summit held in the U.K last we...
Psychedelic Stocks,Shroom News First Ever Psychedelic Drug Trial Company Open its Doors in London By Dennis Mutua May 19, 2022 UK based innovative mental health care company offering clinical research support services and psychedelic-assisted therapies Clerkenwell Health will become the first company in London to start psilocybin trials after announcing t...
